RVNC - Revance Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts8577
Avg. Estimate-0.99-1.04-3.65-4.01
Low Estimate-1.3-1.25-3.97-4.78
High Estimate-0.82-0.89-3.45-3.38
Year Ago EPS-1.12-0.85-3.94-3.65
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts1071210
Avg. Estimate2.53M890k2.95M14.53M
Low EstimateN/AN/A300k1.05M
High Estimate5.5M3.5M6M37M
Year Ago Sales487k278k3.73M2.95M
Sales Growth (year/est)419.50%220.10%-20.90%392.50%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.94-0.87-0.91-0.98
EPS Actual-1.12-0.85-0.86-0.96
Difference-0.180.020.050.02
Surprise %-19.10%2.30%5.50%2.00%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.99-1.04-3.65-4.01
7 Days Ago-0.99-1.04-3.65-4.01
30 Days Ago-1.05-1.18-3.68-4.22
60 Days Ago-1.06-1.18-3.68-4.34
90 Days Ago-1.12-1.08-3.76-4.1
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 Days1111
Up Last 30 Days5255
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRVNCIndustrySectorS&P 500
Current Qtr.11.60%N/AN/A0.01
Next Qtr.-22.40%N/AN/A0.05
Current Year7.40%N/AN/A-0.02
Next Year-9.90%N/AN/A0.14
Next 5 Years (per annum)11.60%N/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A